Matches in Wikidata for { <http://www.wikidata.org/entity/Q93016731> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- Q93016731 description "article scientifique publié en 2020" @default.
- Q93016731 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q93016731 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q93016731 description "scientific article published on 01 April 2020" @default.
- Q93016731 description "wetenschappelijk artikel" @default.
- Q93016731 description "наукова стаття, опублікована 1 квітня 2020" @default.
- Q93016731 name "Correction to: Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACA" @default.
- Q93016731 name "Correction to: Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACA" @default.
- Q93016731 type Item @default.
- Q93016731 label "Correction to: Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACA" @default.
- Q93016731 label "Correction to: Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACA" @default.
- Q93016731 prefLabel "Correction to: Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACA" @default.
- Q93016731 prefLabel "Correction to: Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACA" @default.
- Q93016731 P1433 Q93016731-E336E50A-7A66-47A9-927E-E2493FF129E7 @default.
- Q93016731 P1476 Q93016731-57B8E2CD-A8E4-4F44-8C40-EA197FF068F5 @default.
- Q93016731 P2093 Q93016731-11AD40F0-32B0-46F6-9023-A1BCBA74B957 @default.
- Q93016731 P2093 Q93016731-2528BA3D-8830-4AB2-9B98-A4F0DC25B92B @default.
- Q93016731 P2093 Q93016731-2EEB8D50-EB2B-4FEC-8C78-7B0D02D1186E @default.
- Q93016731 P2093 Q93016731-37B45775-0AB3-412A-9067-10188EF2EDBC @default.
- Q93016731 P2093 Q93016731-4405A361-C5E7-47A6-B644-FE4369FCB156 @default.
- Q93016731 P2093 Q93016731-4A38475A-65E8-4D6C-A457-3529EF7A6090 @default.
- Q93016731 P2093 Q93016731-4A751BCB-1CB1-479D-8481-36DDFAC0EC31 @default.
- Q93016731 P2093 Q93016731-4B68404E-A8A1-43A9-9348-AF50AEA2C3AB @default.
- Q93016731 P2093 Q93016731-7ED28741-9488-495A-8F9C-CD7FC4C3E944 @default.
- Q93016731 P2093 Q93016731-8353ACE7-7039-4960-8550-D792B057D742 @default.
- Q93016731 P2093 Q93016731-9223B276-963F-4955-9C5A-D9816D9BA3AB @default.
- Q93016731 P2093 Q93016731-959DBF2A-E4FA-46A5-B4E3-B33CC4BD4170 @default.
- Q93016731 P2093 Q93016731-AD1AAA92-4006-416F-B133-8B072DA57BD2 @default.
- Q93016731 P2093 Q93016731-BE90821F-2212-40BA-B931-29FDB1E92E8B @default.
- Q93016731 P2093 Q93016731-C0397179-6A41-41B3-8BCA-3BB7B198E908 @default.
- Q93016731 P2093 Q93016731-CA87A56E-F6E9-427C-9625-24369E006E60 @default.
- Q93016731 P2093 Q93016731-CC119955-D28B-4536-8013-2A4ED94518B6 @default.
- Q93016731 P2093 Q93016731-DDD58A19-BA7B-4204-B428-214B3338380A @default.
- Q93016731 P2093 Q93016731-EE39DD4D-4138-4891-BA1F-90AE8D5C06C6 @default.
- Q93016731 P304 Q93016731-A90BF2EB-56F7-495F-BB0C-5125F1DEB4CE @default.
- Q93016731 P31 Q93016731-3ED1DF93-FDD9-4252-90D0-B6B612D592D8 @default.
- Q93016731 P31 Q93016731-F5FF338A-B9D8-45F7-B3D9-4527E8E5C759 @default.
- Q93016731 P356 Q93016731-26BFD455-ED97-4E6F-966D-402C35A7B278 @default.
- Q93016731 P433 Q93016731-41D68E21-A35A-4B49-A86A-F6DD17F5090E @default.
- Q93016731 P478 Q93016731-804E8F53-88D1-4120-99B8-960A9FBD84D6 @default.
- Q93016731 P50 Q93016731-C7246506-B50D-400C-9FF1-79D3C9D3A037 @default.
- Q93016731 P577 Q93016731-B8A8513A-288C-479A-891E-384DF54834CE @default.
- Q93016731 P698 Q93016731-C48C2E00-BDCD-4EFC-B66A-4B9B36A22C34 @default.
- Q93016731 P921 Q93016731-02A3CEBC-C295-4641-AA75-104D5F4EF83F @default.
- Q93016731 P921 Q93016731-14142D8D-F107-46BB-A945-AD1F5EDE9F97 @default.
- Q93016731 P356 S00380-019-01374-5 @default.
- Q93016731 P698 30972549 @default.
- Q93016731 P1433 Q15766690 @default.
- Q93016731 P1476 "Correction to: Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study" @default.
- Q93016731 P2093 "ACADEMIE Study Investigators" @default.
- Q93016731 P2093 "Akira Matsunaga" @default.
- Q93016731 P2093 "Dai Shimono" @default.
- Q93016731 P2093 "Eiji Yahiro" @default.
- Q93016731 P2093 "Fumihiro Hoshino" @default.
- Q93016731 P2093 "Hidekazu Sugihara" @default.
- Q93016731 P2093 "Hideto Sako" @default.
- Q93016731 P2093 "Hiroyuki Tanigawa" @default.
- Q93016731 P2093 "Keijiro Saku" @default.
- Q93016731 P2093 "Kenji Norimatsu" @default.
- Q93016731 P2093 "Masahiro Ogawa" @default.
- Q93016731 P2093 "Mikio Fukushima" @default.
- Q93016731 P2093 "Natsumi Morito" @default.
- Q93016731 P2093 "Shin-Ichiro Miura" @default.
- Q93016731 P2093 "Takaaki Kusumoto" @default.
- Q93016731 P2093 "Tetsuro Shirotani" @default.
- Q93016731 P2093 "Yoshihisa Nagata" @default.
- Q93016731 P2093 "Yuhei Shiga" @default.
- Q93016731 P2093 "Yuko Uehara" @default.
- Q93016731 P304 "603-604" @default.
- Q93016731 P31 Q13442814 @default.
- Q93016731 P31 Q1348305 @default.
- Q93016731 P356 "10.1007/S00380-019-01374-5" @default.
- Q93016731 P433 "4" @default.
- Q93016731 P478 "35" @default.
- Q93016731 P50 Q92910073 @default.
- Q93016731 P577 "2020-04-01T00:00:00Z" @default.
- Q93016731 P698 "30972549" @default.
- Q93016731 P921 Q3025883 @default.
- Q93016731 P921 Q988405 @default.